Back to today’s briefing

Story perspectives

Japan Approves First Stem Cell Treatments for Heart and Parkinson's

3/15/2026

42 4 Full Breakdown

Summary

Story summary

Japan approved the world's first medical treatments derived from reprogrammed human cells.
On March 6, 2026, the Ministry of Health granted conditional approval for two products, ReHeart and Amusepri, to treat severe heart failure and Parkinson's disease.
These therapies are developed from induced pluripotent stem cells.
Shinya Yamanaka, a key figure in iPS cell research, emphasized ongoing safety and efficacy trials.

1 of 1

Story summary

Japan approved the world's first medical treatments derived from reprogrammed human cells.
On March 6, 2026, the Ministry of Health granted conditional approval for two products, ReHeart and Amusepri, to treat severe heart failure and Parkinson's disease.
These therapies are developed from induced pluripotent stem cells.
Shinya Yamanaka, a key figure in iPS cell research, emphasized ongoing safety and efficacy trials.